2,865 hedge funds and large institutions have $105B invested in Pfizer in 2024 Q2 according to their latest regulatory filings, with 213 funds opening new positions, 1,177 increasing their positions, 1,238 reducing their positions, and 172 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

5% less repeat investments, than reductions

Existing positions increased: 1,177 | Existing positions reduced: 1,238

1.16% less ownership

Funds ownership: 67.1%65.94% (-1.2%)

40% less call options, than puts

Call options by funds: $2.36B | Put options by funds: $3.9B

Holders
2,865
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
33
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.36B
Puts
$3.9B
Net Calls
Net Calls Change

Top Buyers

1 +$346M
2 +$334M
3 +$233M
4
Citadel Advisors
Citadel Advisors
Florida
+$217M
5
Norges Bank
Norges Bank
Norway
+$199M
Name Holding Trade Value Shares
Change
Change in
Stake
2326
$295K
2327
$295K
2328
$294K
2329
$294K
2330
$294K
2331
$293K
2332
$293K
2333
$292K
2334
$292K
2335
$292K
2336
$292K
2337
$292K
2338
$291K
2339
$291K
2340
$290K
2341
$289K
2342
$289K
2343
$289K
2344
$288K
2345
$288K
2346
$288K
2347
$288K
2348
$288K
2349
$288K
2350
$287K